Olopatadine eye drops (Pazeo, Patanol, Pataday) are used to treat itchy eyes caused by allergies.
Olopatadine Ophthalmic Market contains market size and forecasts of Olopatadine Ophthalmic in Global, including the following market information:
- Global Olopatadine Ophthalmic Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Olopatadine Ophthalmic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Ophthalmic solution 0.1% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Olopatadine Ophthalmic include Novartis, APOTEX, Teva, Sandoz, Wockhardt, USV Private Limited, Mylan, Akorn and Aurobindo Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Olopatadine Ophthalmic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Olopatadine Ophthalmic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Olopatadine Ophthalmic Market Segment Percentages, by Type, 2021 (%)
- Ophthalmic solution 0.1%
- Ophthalmic solution 0.2%
- Ophthalmic solution 0.7%
Global Olopatadine Ophthalmic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Olopatadine Ophthalmic Market Segment Percentages, by Application, 2021 (%)
- Adults
- Pediatric patients
Global Olopatadine Ophthalmic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Olopatadine Ophthalmic Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Olopatadine Ophthalmic revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Olopatadine Ophthalmic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novartis
- APOTEX
- Teva
- Sandoz
- Wockhardt
- USV Private Limited
- Mylan
- Akorn
- Aurobindo Pharma
- Cipla
- Alembic Pharmaceuticals
Industry Market Size
